Central Proteina (Indonesia) Analysis
| CPRO Stock | IDR 50.00 0.00 0.00% |
Central Proteina Prima is overvalued with Real Value of 44.1 and Hype Value of 50.0. The main objective of Central Proteina stock analysis is to determine its intrinsic value, which is an estimate of what Central Proteina Prima is worth, separate from its market price. There are two main types of Central Proteina's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Central Proteina's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Central Proteina's stock to identify patterns and trends that may indicate its future price movements.
The Central Proteina stock is traded in Indonesia on Jakarta Exchange, with the market opening at 09:00:00 and closing at 15:50:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Indonesia.
Central |
Central Stock Analysis Notes
About 49.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.02. Some equities with similar Price to Book (P/B) outperform the market in the long run. Central Proteina Prima recorded earning per share (EPS) of 6.3. The entity had not issued any dividends in recent years. PT Central Proteina Prima Tbk, together with its subsidiaries, operates as an integrated aquaculture company in Indonesia and internationally. PT Central Proteina Prima Tbk was founded in 1980 and is headquartered in Jakarta Selatan, Indonesia. Central Proteina operates under Farm Products classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 1780 people. For more info on Central Proteina Prima please contact the company at 62 21 5019 1788 or go to https://www.cpp.co.id.Central Proteina Prima Investment Alerts
| Central Proteina had very high historical volatility over the last 90 days | |
| Central Proteina Prima has accumulated 1.06 T in total debt. Central Proteina Prima has a current ratio of 0.32, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Central Proteina until it has trouble settling it off, either with new capital or with free cash flow. So, Central Proteina's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Central Proteina Prima sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Central to invest in growth at high rates of return. When we think about Central Proteina's use of debt, we should always consider it together with cash and equity. | |
| About 49.0% of the company shares are held by company insiders |
Central Market Capitalization
The company currently falls under 'Mega-Cap' category with a current market capitalization of 3.1 T. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Central Proteina's market, we take the total number of its shares issued and multiply it by Central Proteina's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Central Profitablity
Central Proteina's profitability indicators refer to fundamental financial ratios that showcase Central Proteina's ability to generate income relative to its revenue or operating costs. If, let's say, Central Proteina is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Central Proteina's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Central Proteina's profitability requires more research than a typical breakdown of Central Proteina's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.05 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.11 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.11. Technical Drivers
As of the 26th of March, Central Proteina shows the Mean Deviation of 0.9561, downside deviation of 4.82, and Risk Adjusted Performance of 0.0198. Central Proteina Prima technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Central Proteina Prima Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Central Proteina middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Central Proteina Prima. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Central Proteina Outstanding Bonds
Central Proteina issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Central Proteina Prima uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Central bonds can be classified according to their maturity, which is the date when Central Proteina Prima has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Central Proteina Predictive Daily Indicators
Central Proteina intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Central Proteina stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Central Proteina Forecast Models
Central Proteina's time-series forecasting models are one of many Central Proteina's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Central Proteina's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Central Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Central Proteina prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Central shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Central Proteina. By using and applying Central Stock analysis, traders can create a robust methodology for identifying Central entry and exit points for their positions.
PT Central Proteina Prima Tbk, together with its subsidiaries, operates as an integrated aquaculture company in Indonesia and internationally. PT Central Proteina Prima Tbk was founded in 1980 and is headquartered in Jakarta Selatan, Indonesia. Central Proteina operates under Farm Products classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 1780 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Central Proteina to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Watchlist Optimization Now
Watchlist OptimizationOptimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
| All Next | Launch Module |
Other Information on Investing in Central Stock
Central Proteina financial ratios help investors to determine whether Central Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Central with respect to the benefits of owning Central Proteina security.